bendamustine hydrochloride has been researched along with Chromosomal Triplication in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonaldi, L; Martines, A; Nabergoj, M; Piazza, F; Pizzi, M; Scapinello, G; Semenzato, G; Trentin, L; Vio, S; Visentin, A | 1 |
1 other study(ies) available for bendamustine hydrochloride and Chromosomal Triplication
Article | Year |
---|---|
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Lineage; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Disease Progression; Female; Genes, Immunoglobulin; Genes, myc; Humans; Immunoglobulin Heavy Chains; Lymphocytes; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Remission Induction; Rituximab; Splenic Neoplasms; Translocation, Genetic; Trisomy | 2018 |